Gabriela K.
- Country
- Poland
- Department
- N/A
Research Overview
- Long-term Safety and Efficacy Evaluation of Ocrelizumab in Multiple Sclerosis Patients from Phase III Studies
- Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion Versus Oral Immediate-Release Carbidopa-Levodopa in Parkinson's Disease with Motor Fluctuations
- Efficacy and Safety Evaluation of Mirodenafil Dihydrochloride in Early Alzheimer's Disease: A Phase 3 Double-Blind, Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 63 of 267 partner sites.
Specializations
Alzheimer Disease and Related Dementias
Investigates disease‑modifying approaches for Alzheimer disease, tauopathies and frontotemporal dementia.
- Early symptomatic Alzheimer disease
- Neurocognitive disorders
- Psychosis associated with Alzheimer disease
Efforts include biomarker‑driven trials and cognitive outcome optimization.
Parkinsonian and Movement Disorders
Targets therapeutic options for Parkinson disease, including motor fluctuations and non‑motor symptoms.
- Motor fluctuations in advanced Parkinson disease
- Early‑stage Parkinson disease
- Apathy in Parkinson disease
Research spans oral, subcutaneous and infusion delivery platforms.
Multiple Sclerosis and Progressive Demyelinating Conditions
Focuses on treatment strategies for relapsing‑remitting multiple sclerosis, primary progressive multiple sclerosis and progressive forms of multiple sclerosis.
- Long‑term safety of ocrelizumab
- Fenebrutinib comparative efficacy
- Adjunctive therapy with RO7268489
Emphasis on disease activity suppression and disability progression.
Migraine and Headache Disorders
Evaluates preventive and acute interventions for migraine and menstrual migraine.
- Lu AG09222 for migraine prevention
- Atogepant for menstrual migraine
Clinical work integrates patient‑reported outcomes and quality‑of‑life metrics.
Neuropathic Pain Syndromes
Addresses chronic pain conditions such as diabetic peripheral neuropathic pain, post‑herpetic neuralgia and distal sensory polyneuropathy.
- GSK3858279 for diabetic peripheral neuropathic pain
- LY3848575 for distal sensory polyneuropathy
- iN1011‑N17‑02 for post‑herpetic neuralgia
Trials prioritize analgesic efficacy and safety profiling.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.